Bilaal.Raja
Company record

AVXL  ANAVEX LIFE SCIENCES CORP.

Trailing twelve months to 2026-06-30, as filed 2026-08-28 and not restated since.
Healthcare

Scale

Market cap
$169m
Revenue TTM
$4m
Net income TTM
$-13m
Free cash flow
—
Composite score
—
Sector rank
#2889

Valuation

P / E
—
EV / EBITDA
—
EV / sales
12.0
FCF yield
—
Yield vs 10-yr
-12.99pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-309.2%
EBITDA margin
—
ROE
-11.6%
ROIC
—
Revenue growth
-22.6%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.